- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
French medical regulator approves Pfizer-BioNTech COVID-19 vaccine
Paris: French medical regulator HAS said on Thursday it had approved the vaccine developed by Pfizer and BioNTech for France's vaccination rollout, after the European Medicines Agency gave its go-ahead on Monday."The vaccine can be used for people aged 16 and over, including elderly", the regulator says.Read also: Pfizer, BioNTech COVID vaccine gets EU regulatory nod, inoculation to start...
Paris: French medical regulator HAS said on Thursday it had approved the vaccine developed by Pfizer and BioNTech for France's vaccination rollout, after the European Medicines Agency gave its go-ahead on Monday.
"The vaccine can be used for people aged 16 and over, including elderly", the regulator says.
Read also: Pfizer, BioNTech COVID vaccine gets EU regulatory nod, inoculation to start from Dec 27
The European Union is gearing up for a vaccination campaign of unprecedented scale following regulatory approval for the shot. France plans to start its vaccination programme on Dec. 27.
Read also: India likely to get COVID-19 vaccine approved for emergency use before December ends: Report
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751